MedTrace Logo

Investigation of Kritech Efficacy on Subjects Having Functional Discomfort Associated to Joints and Muscles Disorders

NCT02318875 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2014-12-17

No results posted yet for this study

Summary

Joints and muscles disorders are common symptoms in the population. They are characterized by swelling, pain, functional impairment and morning stiffness. These disorders can be really disabling and painful, affecting the person's quality life. The purpose of this clinical trial is to test Kritech (Krill oil) efficacy in reducing these symptoms in 154 subjects complaining functional discomfort associated to joints and muscles disorders.

Conditions

Interventions

DIETARY_SUPPLEMENT

Kritech administration

300mg/day (1 capsule) during 12 weeks; oral ingestion

OTHER

Placebo adminstration

1 placebo capsule per day during 12 weeks; oral ingestion

Sponsors & Collaborators

  • Vivatech

    lead INDUSTRY

Principal Investigators

  • Nicholas Moore, Professor · University Hospital Bordeaux, France

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02318875 on ClinicalTrials.gov